Welcome to the Alaska Chapter of the American College of Cardiology
Welcome to the Alaska Chapter of the American College of Cardiology
|
16th Annual Cardiovascular Update Conference February 6th and 7th from 8:00 am - 5:00 pm For details visit: Registration Page |
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings
Latest in Cardiology from ACC.org
- Indexing Ascending Aortic Dimensions to Height vs. Absolute Diameter to Identify High-Risk PatientsIndexing ascending aortopathy (AA) to height better identifies patients, especially women, who could benefit from earlier surgery rather than absolute diameters, according to a recent study published in JACC: Advances.
- Higher TAVR Volume Associated With Lower Complications, Not Lower Failure to Rescue Rates | NCDR StudyHigher annualized TAVR volume is associated with lower complication rates but not with lower failure to rescue (FTR) rates, according to a recent study published in JACC: Cardiovascular Interventions.
- OPTIMA-AF: 1-Month vs. 12-Month Dual Antithrombotic Therapy Post PCIOnly one month of dual antithrombotic therapy followed by direct oral anticoagulant (DOAC) monotherapy proved to be noninferior in terms of efficacy and superior in terms of bleeding outcomes to the standard 12-month dual antithrombotic therapy post PCI among patients with atrial fibrillation (AFib), according to results of the OPTIMA-AF trial published July 15 in […]
- Micro- and Nanoplastics Found in Patients With STEMI, CCSLevels of microplastics and nanoplastics (MNPs) in coronary blood were higher in patients with a STEMI than those with chronic coronary syndromes (CCS) or in controls, according to a cross-sectional study published July 14 in the EHJ.
- Better Safety Profile, TR Reduction With T-TEER Than TTVA, Similar Outcomes at 1 YearIn patients with severe secondary tricuspid regurgitation (TR), tricuspid valve transcatheter edge-to-edge repair (T-TEER), compared with transcatheter tricuspid valve annuloplasty (TTVA), showed a more favorable safety profile and a more effective and durable reduction in TR, while clinical outcomes at one year were similar with both strategies, according to research published July 22 in JACC: […]
